RNXT
RenovoRx Inc
NASDAQ: RNXT · HEALTHCARE · BIOTECHNOLOGY
$0.85
+2.27% today
Updated 2026-04-30
Market cap
$37.84M
P/E ratio
—
P/S ratio
33.70x
EPS (TTM)
$-0.32
Dividend yield
—
52W range
$1 – $1
Volume
0.4M
RenovoRx Inc (RNXT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-1,270.00%
ROE
-225.60%
ROA
-92.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-3.84M | — | — | — |
| 2020 | $0.00 | $-3.80M | — | — | — |
| 2021 | $0.00 | $-6.32M | — | — | — |
| 2022 | $0.00 | $-9.77M | — | — | — |
| 2023 | $0.00 | $-10.23M | — | — | — |
| 2024 | $43000.00 | $-8.81M | 100.00% | -25,511.63% | -20,497.67% |
| 2025 | $1.12M | $-11.17M | 70.88% | -1,113.98% | -994.48% |